We refer to the excellent, timely review by Lisman et al
[1] Lisman T. Caldwell S.H. Intagliata N.M. Haemostatic alterations and management of haemostasis in patients with cirrhosis.
J Hepatol. 2022 Jun 1; 76 : 1291-1305 Google Scholar
on “Hemostatic alterations and management of haemostasis in patients with cirrhosis”. Children with advanced liver disease awaiting liver transplantation or close to listing are at high risk of losing portal venous flow and portal thrombosis because of high hepatic resistance and a fragile, rebalanced hemostatic state. Loss of portal flow is reported to herald irreversible portal thrombosis, hepatocyte extinction with worsening hepatocyte function and risk of portal vein clot extension
[2] Iranpour P. Lall C. Houshyar R. Helmy M. Yang A. Choi J.I. Ward G. Goodwin S.C. Altered Doppler flow patterns in cirrhosis patients: an overview.
J Ultrason. 2016 Jan; 35 : 3 Google Scholar
. Treatment with anti-coagulation has been proposed for this complication but there is little published experience, especially in children. We report our experience from a statewide, paediatric liver transplant service after commencing a policy of frequent doppler ultrasound to monitor for and treat reversal of portal flow in children with end stage liver disease (Table 1).